- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06565832
Reproducibility of Virtual Exercise Assessments Versus Face-to-face Exercise Testing in Adults With Cystic Fibrosis (RExA-CF)
August 21, 2024 updated by: Royal Brompton & Harefield NHS Foundation Trust
Reproducibility of Virtual Exercise Assessments Versus Face-to-face Exercise Testing in Adults With Cystic Fibrosis - a Pilot Feasibility Study
RExA-CF is investing if results from exercise tests (the Chester Step Test and the One-Minute Sit-to-Stand test) completed face to face are comparable to results of the same tests completed via a virtual teleconferencing platform.
The study involves two exercise testing sessions (one face-to-face and one via a video link), with participants being randomised to complete the two exercise tests (the 1-minute sit-to-stand test and the Chester Step test).
The two testing sessions will be completed within three weeks of each other, the order of which will be randomly allocated.
One session will be completed face-to-face during a pre-arranged visit to the hospital, the other test session will be completed through a video call at a time convenient to the participants.
After the second testing session participants will be asked some questions about the face-to-face and video tests to get their views about the two formats.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
19
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
London, United Kingdom, SW3 6NP
- Royal Brompton Hospital, Guy's and St Thomas's NHS Foundation Trust
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Diagnosis of cystic fibrosis (as confirmed by standard criteria)
- Sixteen years of age or over
- Home internet access
- Stable CF disease as judged by the medical team
- Registered with the Royal Brompton Hospital adult CF team
Exclusion Criteria:
- Inability to give consent for treatment or measurement
- Current participation in another interventional study
- Current moderate haemoptysis (greater than streaking in the sputum)
- Pregnancy
- Forced expiratory volume in 1 second (FEV1) below 30% predicted
- Dependency upon oxygen therapy (with home oxygen concentrators or portable oxygen cylinders) or non-invasive ventilation (NIV)
- Current neurological or musculoskeletal injury which would prevent completion of exercise tests
- Inability to complete the second set of exercise tests within three weeks
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Virtual exercise testing via video link
The One-Minute Sit-to-Stand test and the Chester Step test will be completed via a video link call with the participant and the research team.
|
This test involves sitting down and standing up from a normal height chair (can be a dining room or kitchen chair at home) for one minute.
Participants can rest or stop at any time if fatigued.
Participants will be asked to record your heart rate and oxygen levels before and after the test and will be given a monitor to do this with if they do not already have one.
This test should take a maximum of 5 minutes.
This test involves the participant stepping up and down off of a step (this can be a bottom stair or doorstep at home) keeping up with the beat of a recording.
The speed of the beat increases every 2 minutes, and the test continues until the participant cannot keep up with the pace, wish to stop or the test ends which takes 10 minutes.
Participants will be asked to record heart rate and oxygen levels before and after the test.
This test should take a maximum of 15 minutes.
|
|
Active Comparator: Face-to-Face exercise testing
The One-Minute Sit-to-Stand test and the Chester Step test will be completed face to face at a hospital appointment with the participant and the research team.
|
This test involves sitting down and standing up from a normal height chair (can be a dining room or kitchen chair at home) for one minute.
Participants can rest or stop at any time if fatigued.
Participants will be asked to record your heart rate and oxygen levels before and after the test and will be given a monitor to do this with if they do not already have one.
This test should take a maximum of 5 minutes.
This test involves the participant stepping up and down off of a step (this can be a bottom stair or doorstep at home) keeping up with the beat of a recording.
The speed of the beat increases every 2 minutes, and the test continues until the participant cannot keep up with the pace, wish to stop or the test ends which takes 10 minutes.
Participants will be asked to record heart rate and oxygen levels before and after the test.
This test should take a maximum of 15 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Aerobic Capacity from the Chester Step test
Time Frame: Completed at week 0 and within 2 weeks of first test
|
This test involves the participant stepping up and down off of a step (this can be a bottom stair or doorstep at home) keeping up with the beat of a recording.
The speed of the beat increases every 2 minutes, and the test continues until the participant cannot keep up with the pace, wish to stop or the test ends which takes 10 minutes.
Participants will be asked to take their heart rate and oxygen levels before and after the test using a provided pulse-oximeter.
This test should take a maximum of 15 minutes.
The results of the test will be used to calculate the participants aerobic capacity (range 0-60)
|
Completed at week 0 and within 2 weeks of first test
|
|
Number of sit to stands completed during One-Minute Sit-to-Stand test
Time Frame: Completed at week 0 and within 2 weeks of first test
|
This test involves the participant sitting down and standing up from a normal height chair (can be a dining room or kitchen chair at home) for one minute.
Participants can rest or stop at any time if fatigued.
This test should take a maximum of 5 minutes.
|
Completed at week 0 and within 2 weeks of first test
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Gemma E Stanford, Royal Brompton & Harefield NHS Foundation Trust
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2023
Primary Completion (Actual)
August 1, 2023
Study Completion (Actual)
August 1, 2023
Study Registration Dates
First Submitted
August 14, 2024
First Submitted That Met QC Criteria
August 21, 2024
First Posted (Actual)
August 22, 2024
Study Record Updates
Last Update Posted (Actual)
August 22, 2024
Last Update Submitted That Met QC Criteria
August 21, 2024
Last Verified
August 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RExA-CF V3
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cystic Fibrosis
-
Hospital de Clinicas de Porto AlegreUnknownCystic Fibrosis | Cystic Fibrosis Pulmonary Exacerbation | Cystic Fibrosis in Children | Cystic Fibrosis With ExacerbationBrazil
-
Dartmouth-Hitchcock Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingCystic Fibrosis (CF) | Cystic Fibrosis Gastrointestinal DiseaseUnited States
-
Reistone Biopharma Company LimitedRecruiting
-
AstraZenecaRecruitingNon-cystic Fibrosis BronchiectasisChina
-
Alexander HorsleyRecruitingCystic Fibrosis (CF) | Cystic Fibrosis Pulmonary ExacerbationUnited Kingdom
-
University of Colorado, DenverCystic Fibrosis FoundationTerminatedCystic Fibrosis-related Diabetes | Cystic Fibrosis Pulmonary Exacerbation | Cystic Fibrosis in ChildrenUnited States
-
Royal College of Surgeons, IrelandThe Hospital for Sick Children; Imperial College London; Erasmus Medical Center; University College Dublin and other collaboratorsActive, not recruitingCystic Fibrosis | Adherence, Medication | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis in Children | Cystic Fibrosis Liver DiseaseUnited Kingdom, Ireland
-
Herlev and Gentofte HospitalCopenhagen University Hospital, DenmarkActive, not recruitingMyocardial Infarction | Heart Diseases | Heart Failure | Stroke | Cystic Fibrosis | Heart Failure, Diastolic | Heart Failure, Systolic | Left Ventricular Dysfunction | Cystic Fibrosis-related Diabetes | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis of Pancreas | Cystic Fibrosis, Pulmonary | Cystic...Denmark
-
Alexander HorsleyRecruitingCystic Fibrosis (CF) | Cystic Fibrosis Pulmonary ExacerbationUnited Kingdom
-
The Hospital for Sick ChildrenCanadian Cystic Fibrosis FoundationActive, not recruitingCystic Fibrosis | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis in ChildrenCanada
Clinical Trials on One-Minute Sit-to-Stand Test
-
Universidad Católica San Antonio de MurciaCompleted
-
University of ZurichCompletedHealthy IndividualsSwitzerland
-
Centro Universitário Augusto MottaRecruitingHeart Failure | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure NYHA Class IV | Heart Failure; With DecompensationBrazil
-
University of ZurichCompletedPulmonary Disease, Chronic ObstructiveSwitzerland
-
Boston Children's HospitalCompleted
-
Groupe Hospitalier du HavreCompleted
-
Cliniques universitaires Saint-Luc- Université...Completed
-
University Hospital, GrenobleCompletedIdiopathic Pulmonary FibrosisFrance
-
Cliniques universitaires Saint-Luc- Université...Completed
-
Hacettepe UniversityUnknownExercise Capacity | Cystic Fibrosis in ChildrenTurkey